A broad range of vitamins and minerals helps supplement dietary intake when food alone falls short.*
This is Part 2 of our leave benefits series
J Obes Metab Syndr 32(1):2545 Tian S, Zhou S, Wu W, lin Y, Wang T, Sun H, et al (2025) GLP-1 Receptor agonists alleviate diabetic kidney injury via -klotho-mediated ferroptosis inhibition
Separate Weight Watchers Med+ membership required Membership starts at $25 for the first month ^^
The ESETT trial (NEJM 2019, N=384) established LEVETIRACETAM as NOT INFERIOR to phenytoin and valproate as second-line therapy, with the advantage of fewer adverse effects (no hypotension, no cardiac arrhythmias, no infusion reactions)
Innovations like GLP-1 patches represent additional delivery innovations that could reduce costs while improving patient adherence